Biocon gets six-month extension on insulin supply pact in Malaysia
Biocon Biologics Limited( BBL) has announced that the Government of Malaysia has agreed to extend the current contract period of 36 months under the existing insulin supply agreement with its subsidiary in Malaysia, Biocon Sdn. Bhd., and Duopharma Marketing Sdn. Bhd.( DMktg), for an additional six months effective from April 29, 2025 until October 28, 2025.
Mapmygenome cements global leadership in genomics with strategic acquisition of Microbiome Insights
Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights’ CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome’ s scientific prowess and enabling its global expansion.
BioTech
Govt of Tamil Nadu in association with C-CAMP hosts roundtable on health
The Centre for Cellular and Molecular Platforms( C-CAMP), a deep-science innovation hub, has announced a partnership with the Government of Tamil Nadu with the aim to strengthen public health system in the state, through indigenous and innovative health technologies. Through this strategic initiative, CSR and Philanthropy partners can enable joint projects led by the Govt. of Tamil Nadu and C-CAMP, aimed at implementing the much-needed innovative health technologies in the state through pilot and scale-up programmes.
BIOVOICENEWS. COM 09